Vinorelbine: An overview

Cancer Treatment Reviews

Volumn 22, Issue 2, 1996, Pages 127-142

  Johnson, S A ^a   Harper, P ^b   Hortobagyi, G N ^c   Pouillart, P ^d  

^a TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TEXAS   (United States)

^d INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NAVELBINE; VINBLASTINE SULFATE; VINCRISTINE; VINCRISTINE SULFATE; VINDESINE;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG STRUCTURE; DRUG TOLERABILITY; HUMAN; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; REVIEW;

EID: 0030062196     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(96)90032-8     Document Type: Article

References (88)

1. Johnson, I. S., Wright, H. F., Svoboda, G. H. & Vlantis, J. (1960) Antitumor principles derived from vinca rosea Linn: I. vinca leucoblastine and leurosine. Cancer Res. 20: 1016-1022.
2. Mangeney, P., Andriamialisoa, R. Z., Lallemand, J.-Y, Langlois, N., Langlois, Y. & Potier, P. (1979) 5′Nor-anhydrovinblastine, prototype of a new class of vinblastine derivatives. Tetrahedron 35: 2175-2179.
3. Weisenberg, R. C. (1972) Microtubule formation in solutions containing low calcium concentrations. Science 177: 1104-1105.
4. R on various types of microtubules using immunofluorescence. Sem. Oncol. 16 (Suppl. 4): 5-8.
5. R on tubulin and associated proteins. Sem. Oncol. 16 (Suppl. 4): 9-14.
6. Binet, S., Chaineau, E., Fellous, A. et al. (1990) Immunofluorescence study of the action of Navelbine, vincristine and vinblastine on mitotic and axonal microtubules. Int. J. Cancer 46: 262-266.
7. R. Sem. Oncol. 16 (Suppl. 4): 15-20.
8. R (NVB) in a human non-small cell lung cancer (NSCLC) line. Proc. Am. Ass. Cancer Res. 36: A3637.
9. Maral, N., Bourut, C., Chenu, E. & Mathe, G. (1984) Experimental antitumour activity of 5′-noranhydro-vinblastine (Navelbine). Cancer Lett. 22: 49-54.
10. Ashizawa, T., Miyoshi, K., Asada, M. et al. (1993) Antitumour activity of Navelbine (vinorelbine ditartrate), a new vinca-alkaloid analog. Jpn. J. Cancer Chemother. 20: 59-66.
11. Otter, G. M. & Sirotnak, F. M. (1994) Effective combination therapy of metastatic murine solid tumours with edatrexate and the vinca alkaloids, vinblastine, Navelbine and vindesine. Cancer Chemother. Pharmacol. 33: 268-290.
12. Tsuruo, T., Inaba, M., Tashiro, T. et al. (1993) Evaluation of antitumour activity of Navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice. Anticancer Drugs 5: 634-640.
13. Ashizawa, T., Asada, M., Kobayashi, E., Okabe, M., Gomi, K. & Hi rata, T. (1993) Combination effect of Navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukaemia and human lung carcinoma xenografts in mice. Anticancer Drugs 4: 577-583.
14. Van Den Berge, D., Bruyneel, E., Distelmans, W. et al. (1993) 5′nor-anhydrovinblastine (Navelbine) has an anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro and in vivo. Anticancer Res. 13: 273-278.
15. Bonfil, R. D., Russo, D. M. & Schmilovich, A. J. (1995) Anti-proliferative and anti-invasive effects of vinorelbine in transitional cell carcinoma of the bladder. Proc. Am. Ass. Cancer Res. 36: A2083.
16. R). Invest. New Drugs 13: 13-21.
17. Rhamani, R., Bruno, R., Iliadis, A. et al. (1987) Clinical pharmacokinetics of the antitumour drug Navelbine. Cancer Res. 47: 5796-5799.
18. Marquet, P., Lachatre, G., Debord, J., Eichler, B., Bonnaud, F. & Nicot, G. (1992) Pharmacokinetics of vinorelbine in man. Eur. J. Clin. Pharmacol. 42: 545-547.
19. Zhou, X. J., Bore, R., Monjanel, S. et al. Pharmacokinetics of Navelbine after oral administration in cancer patients. Cancer Chemother. Pharmacol. 29: 66-70.
20. Rowinsky, E. K., Noe, D. A., Trump, D. L. et al. (1994) Pharmacokinetic, bioavailability and feasibility study of vinorelbine in patients with solid tumors. J. Clin. Oncol. 12: 1754-1763.
21. Variol, P., Puozzo, C., Chevallier, B. et al. (1996) Pharmacokinetics of oral vinorelbine in women with advanced breast cancer. Proc. Am. Ass. Cancer Res. 37: A1229.
22. R in humans as determined by high performance liquid chromatography. Cancer Res. 51: 2073-2076.
23. Mathe, G. & Reizenstein, P. (1985) Phase I pharmacologic study of a new vinca alkaloid: Navelbine. Cancer Lett. 27: 285-293.
24. Furuse, K., Niitani, H., Wakui, A. et al. (1989) Phase I study of vinorelbine (Navelbine) by single or intermittent administration. Invest. New Drugs 7: 456, A31.
25. Khayat, D., Covelli, A., Variol, P., Benhamouda, A., Jacques, C. & Bugat, R. (1995) Phase I and pharmacologic study of intravenous vinorelbine in patients with solid tumours. Proc. Am. Soc. Clin. Oncol. 14: A1518.
26. Schilling, T., Fiebig, H. H., Fromm, M. et al. Phase I clinical and Pharmacokinetic trial of the new vinca alkaloid vinorelbine. Onkologie 17 (Suppl. 2): A508.
27. Leveque, D., Quoix, E., Dumont, P. et al. (1993) Pulmonary distribution of vinorelbine in patients with non-small cell lung cancer. Cancer Chemother. Pharmacol. 33: 176-178.
28. Depierre, A., Lemarie, E., Dabouis, G., Garnier, G., Jacoulet, P. & Dalphin J. C. (1991) A phase II study of Navelbine in the treatment of non-small cell lung cancer. Am. J. Oncol. 14: 115-119.
29. Furuse, K., Kubota, K., Kawahara, M. et al. (1994) A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Lung Cancer 11: 385-391.
30. Crivellari, D., Veronesi, A., Sacco, C. et al. (1994) Phase II study of vinorelbine (V) in 50 patients (pts) with non-small cell lung cancer (NSCLC). Proc. Am. Soc. Clin. Oncol. 13: A1192.
31. Pronzata, P., Landucci, M., Vaira, F., Vigani, A. & Bertelli, G. (1994) Failure of vinorelbine to produce responses in pre-treated non-small cell lung cancer patients. Anticancer Res. 14: 1413-1415.
32. R in a randomised controlled trial. Proc. Am. Soc. Clin. Oncol. 12: 343 (Abstract 1148).
33. Depierre, A., Chastang, C., Quoix, E. et al. (1994) Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomised trial. Ann. Oncol. 5: 37-42.
34. Le Chevalier, T., Brisgand, D., Douillard, J. Y. et al. (1994) Randomised study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicentre trial including 612 patients. J. Clin. Oncol. 12: 360-367.
35. Smith, T. J., Hillner, B. E., Neighbors, D. M., McSorley, P. A. & Le Chevalier, T. (1995) Economic evaluation of a randomised clinical trial comparing vinorelbine, vinorelbine plus cisplatin and vindesine plus cisplatin for non-small cell lung cancer. J. Clin. Oncol. 13: 2166-2173.
36. Vokes, E. E., Rosenberg, R. K., Jahanzeb, M. et al. Multicenter phase II study of weekly oral Vinorelbine for stage IV non-small cell lung cancer. J. Clin. Oncol. 13: 637-644.
37. Gebbia, V., Caruso, M., Valenza, R. et al. (1994) Vinorelbine plus cisplatin for the treatment of stage IIIB and IV non-small cell lung carcinoma. Anticancer Res. 14: 1247-1249.
38. Viallet, J., Ayoub, J., Rousseau, P., Souhami, L., Hohneker, J. & Shepherd, F. (1994) Vinorelbine (Navelbine) in the adjuvant and neo-adjuvant treatment of non-small cell lung cancer. Sem. Oncol. 21 (Suppl. 10): 64-72.
39. Viallet, J., Rousseau, P., Souhama, L. et al. (1995) A completed phase I/II trial of neoadjuvant chemotherapy (CT) with cisplatin and vinorelbine followed by accelerated thoracic irradiation (TRT) in operable NSCLC. Proc. 8th Eur. Conf. Clin. Oncol.; Eur. J. Cancer 31A (Suppl. 5): A1083.
40. Masotti, A., Borzellino, G., Zannini, G., Laterza, E., Ricci, F. & Morandini, G. (1995) Efficacy and toxicity of vinorelbine - carboplatin combination in the treatment of advanced adenocarcinoma or large cell carcinoma of the lung. Tumori. 81: 112-116.
41. Crawford, J. & O'Rourke, M. A. (1994) Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor. Sem. Oncol. 21 (Suppl. 10): 73-78.
42. Baldini, E., Tibaldi, C., Chella, A. et al. (1994) Combination chemotherapy with vinorelbine, ifosfamide and cisplatin: a phase II study in stage IIIB/IV non-small cell lung cancer. Sem. Oncol. 21 (Suppl. 4): 12-15.
43. Souquet, P. J., Fournel, P., Bohas, C. H., Court-Fortune, I., Emonot, A. & Bernard, J. P. (1994) A phase II trial of cisplatin (CDDP), ifosfamide (IFM) and increasing dosage of vinorelbine (NVB) (NIP) in non-resectable non small cell lung cancer (NSCLC). Proc. Eur. Soc. Med. Oncol.; Ann. Oncol. 5 (Suppl. 8): A759.
44. Canobbio, L., Boccardo, F., Pastorino, G. et al. (1989) Phase II study of Navelbine in advanced breast cancer. Sem. Oncol. 16 (Suppl. 4): 33-36.
45. Fumoleau, P., Delgado, F. M., Delozier, T. et al. (1993) Phase II trial of weekly intravenous vinorelbine in first line advanced breast cancer chemotherapy. J. Clin. Oncol. 11: 1245-1252.
46. Garcia-Conde, J., Lluch, A., Martin, M. et al. (1994) Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy. Ann. Oncol. 5: 854-857.
47. Bruno, S., Puerto, L., Mickiewicz, E. et al. (1995) Phase II trial of weekly IV vinorelbine as a single agent in first-line advanced breast cancer. The Latin-American experience. Am. J. Clin. Oncol. 18: 392-396.
48. Romero, A., Rabinovich, M. G., Vallejo, C. T. et al. (1994) Vinorelbine as first-line chemotherapy for metastatic breast carcinoma. J. Clin. Oncol. 12: 336-341.
49. Twelves, C. J., Dobbs, N. A., Curnow, A. et al. (1994) A phase II multicentre UK study of vinorelbine in advanced breast cancer. Br. J. Cancer 70: 990-993.
50. Weber, B. L., Vogel, C., Jones, S. et al. (1995) Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer. J. Clin. Oncol. 13: 2722-2730.
51. Marty, M., Leandri, S., Extra, J. M., Espie, M. & Besenval, M. (1989) A phase II study of vinorelbine (NVB) in patients with advanced breast cancer (BC). Proc. Am. Assoc. Cancer Res. 30: 256, A1017.
52. Tresca, P., Fumoleau, P., Roche, H. et al. (1990) Vinorelbine an active new drug in breast carcinoma: results of an ARTAC phase II trial. Proc. 13th Ann. San Antonio Breast Cancer Symposium 16: A66.
53. Degardin, M., Bonneterre, J., Hecquet, B. et al. (1994) Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancer. Ann. Oncol. 5: 423-426.
54. Gasparini, G., Caffo, O., Barni, S. et al. (1994) Vinorelbine is an active anti-proliferative agent in pre-treated advanced breast cancer patients: a phase II study. J. Clin. Oncol. 12: 2094-2101.
55. Toussaint, C., Izzo, J., Spielmann, M. et al. (1994) Phase I/II trial of continuous infusion of Navelbine for advanced breast cancer. J. Clin. Oncol. 12: 2102-2112.
56. Jones, S., Winer, E., Vogel, C. et al. (1995) Randomised comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer. J. Clin. Oncol. 13: 2567-2574.
57. Spielmann, M., Dorval, T., Turpin, F. et al. (1994) Phase II trial of vinorelbine/doxorubicin as first line therapy of advanced breast cancer. J. Clin. Oncol. 12: 1764-1770.
58. Hochster, H., Vogel, C., Blumenreich, M. et al. (1994) A multicenter phase II study of Navelbine (NVB) and doxorubicin (Dox) as first-line chemotherapy of metastatic breast cancer. Proc. Am. Soc. Clin. Oncol. 13: A203.
59. Blajman, C., Balbiani, L., Block, J. et al. (1993) Navelbine (N) and adriamycin (A) versus FAC in advanced breast cancer. Proc. Am. Soc. Clin. Oncol. 12: 92, A170.
60. Froudarakis, M., Catimel, G., Guastalla, J. P. Rebattu, P. & Clavel, M. (1992) Phase II study of Navelbine and 5-fluorouracil as second line chemotherapy in metastatic breast cancer. Proc. Eur. Soc. Med. Onc. Abstract 343, Ann. Oncol. 3 (Suppl. 4): 88.
61. Dieras, V., Pierga, J. Y., Extra, J. M. et al. (1992) Results of a combination of Navelbine and fluorouracil in advanced breast cancer with a group sequential design. Proc. Eur. Soc. Med. Onc. Abstract 178, Ann. Oncol. 3 (Suppl. 4): 46.
62. Chadjaa, M., Izzo, J., May-Levin, F., Riggi, M., Cvitkovic, E. & Armand, J. P. (1993) Preminary data on 4′epiadriamycine, vinorelbine: a new active combination in advanced breast cancer. Proc. Am. Soc. Clin. Oncol. 12: A152.
63. Van Praagh, I., Martineau, N., Cure, H. et al. (1993) Efficacy of a chemotherapy regimen combining vinorelbine, epirubicine and methotrexate (VEM) in locally advanced and metastatic breast cancer. Proc. Am. Soc. Clin. Oncol. 12: 95, A180.
64. Van Praagh, I., Leduc, B., Feillel, V. et al. (1995) Neoadjuvant VEM chemotherapy regimen for operable breast cancer: result of a co-operative study on 69 patients. Proc. Am. Soc. Clin. Oncol. 14: A242.
65. Chollet, P. H., Charrier, S., Brain, E. et al. (1995) Neo-adjuvant chemotherapy in breast cancer. High pathological response rate induced by intensive anthracycline-based regimen. Proc. Am. Soc. Clin. Oncol. 14: 130, A218.
66. Ferrero, J. M., Wendling, J. L., Hoch, M., Frenay, M., Francois, E. & Namer, M. (1993) Mitoxantrone-vinorelbine as first line therapy in metastatic breast cancer. Proc. Am. Soc. Clin. Oncol. 12: 108, A234.
67. Kayitalire, L., Spielmann, M., Brain, E. et al. (1993) Salvage chemotherapy (CT) with combination of mitoxantrone (MTZ) and vinorelbine (VRB) in resistant to anthracyclines advanced breast cancer (ABC). Proc. Am. Soc. Clin. Oncol. 12: 90, A161.
68. R) by simultaneous (Sim) 3 hour (h) infusion (inf) with G-CSF support, for untreated metastatic breast cancer (MBC). Proc. Am. Assoc. Cancer Res. 36: A1443.
69. Fumoleau, P., Delecroix, V., Gentin, M. et al. (1995) Docetaxel (D) in combination with vinorelbine (V) as first-line CT in pts with MBC: phase I dose finding study. Proc. Eur. Conf. Clin. Oncol.; Eur. J. Cancer 31A (Suppl. 5): A1083.
70. Fabi, A., Tonachella, R., Savarese, A. et al. (1995) A phase II trial of vinorelbine and thiotepa in metastatic breast cancer. Ann. Oncol. 6: 187-189.
71. George, M. J., Heron, J. F., Kerbrat, P. et al. (1989) Navelbine in advanced ovarian epithelial cancer: a study of the French Oncology Centers. Sem. Oncol. 16 (Suppl. 4): 30-32.
72. Pinel, M. C., Pinon, G., Goudier, M. J. et al. (1990) Navelbine and hexamethylmelamine as second or further line chemotherapy regimen in advanced ovarian carcinoma: an ARTAC phase II study. Proc. Am. Soc. Clin. Oncol. 9: 166, A644.
73. R) in previously treated Hodgkin's Disease and Non-Hodgkin's lymphomas. In: Celigny, P. S., ed. Navelbine (Vinorelbine) Up-date and New Trends. Paris, London: John Libby Eurotext, pp. 261-264.
74. Devizzi, L., Santoro, A., Bonfante, V. et al. (1994) Vinorelbine: an active drug for the management of patients with heavily pre-treated Hodgkin's Disease. Ann Oncol 5: 817-820.
75. Ferme, C., Bastion, Y., Lepage, E. et al (1995) The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's Disease. Ann. Oncol. 6: 543-549.
76. Conroy, T., Etienne, P. L., Adenis, A. et al. for the EORTC Gastrointestinal Tract Cancer Cooperative Group (1996) Phase II trial of Vinorelbine in metastatic squamous cell esophageal carcinoma. J. Clin. Oncol. 14: 164-170.
77. Testolin, A., Recher, G., Cristoferi, V. & Gasparini, G. (1994). Vinorelbine in pre-treated advanced head and neck squamous cell carcinoma. Invest. New Drugs 12: 231-234.
78. Gebbia, V., Testa, A., Valenza, R. et al. (1993) A pilot study of Vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Eur. J. Cancer 29A: 1358-1359.
79. Gebbia, V., Mantovani, G., Agostara, B. et al. (1995) Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin and 5-fluorouracil: a multicenter phase II trial. Ann. Oncol. 6: 987-991.
80. R) in previously treated small cell lung cancer patients. Eur. J. Cancer 29A: 1720-1722.
81. Depierre, A., Le Chevalier, T., Quoix, E. et al. (1995) Phase II study of Navelbine (NVB) in small cell lung cancer (SCLC). Proc. Am. Soc. Clin. Oncol. 14: A1050.
82. Fields, S., Burris, H. A., Wilding, G. et al. (1994) Evaluating the role of Navelbine in hormone-refractory prostate cancer (HRPC): a clinical benefit model. Proc. Am. Soc. Clin. Oncol. 13: A727.
83. Morris, M., Burke, T., Levenback, C., Wharton, J. T. & Gershenson, D. (1995) Phase II study Vinorelbine in advanced squamous carcinoma of the uterine cervix (SCC): preliminary results. Proc. Am. Soc. Clin. Oncol. 14: A742.
84. Canobbio, L., Boccardo, F., Guarneri, D. et al. (1991) Phase II study of Navelbine in advanced renal cell carcinoma. Eur. J. Cancer 27: 804-805.
85. Fumoleau, P., Delozier, T., Extra, J. M., Canobbio, L., Delgado, F. M. & Hurteloup, P. (1995) Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience. Sem. Oncol. 22 (Suppl. 5): 22-29.
86. Brosio, C., Cinat, G., Mickiewicz, E. et al. (1993) Granulocytic colony stimulating factors support in weekly chemotherapy with vinorelbine. Proc. Am. Soc. Clin. Oncol. 12: 144, A377.
87. Hohneker, J. (1994) A summary of vinorelbine (Navelbine) safety data from North American Clinical Trials. Sem. Oncol. 21 (Suppl. 10): 42-47.
88. R). Oncol. News Forum 22: 707-710.